Company Profile
| name | SymBio Pharmaceuticals Limited | |
|---|---|---|
| English name | SymBio Pharmaceuticals Limited | |
| location |
Toranomon Towers Office, 7th floor, 4-1-28 Toranomon, Minato-ku, Tokyo 105-0001, Japan MAP TEL: +81-3-5472-1125 FAX: +81-3-5472-3054 For Inquiry about brincidofovir: +81-3-6684-6663 |
|
| Established | March 25, 2005 | |
| capital | 18,336,841 thousands of yen (As of the end of December 2024) | |
| Board of Directors | Fuminori Yoshida | Representative Director |
| Hiroshi Nomura | Board Director <Outside> | |
| Bruce David Cheson | Board Director <Outside> | |
| George Morstyn | Board Director <Outside> | |
| Ralph Smalling | Board Director <Outside> | |
| Koichi Shimomura | Board Director, Full-Time Audit & Supervisory Committee Member<Outside> | |
| Eiji Mizutani | Board Director, Audit & Supervisory Committee Member<Outside> | |
| Tsuyoshi Ichinosawa | Board Director, Audit & Supervisory Committee Member<Outside> | |
| Corporate Officer | Fuminori Yoshida | President and Chief Executive Officer |
| Edwin Rock | Corporate Vice President and Head of Global R&D Division | |
| Paul Marston | Managing Corporate Officer and General Counsel | |
| Takeo Okuno | Corporate Officer and Chief Financial Officer | |
| Minori Rosales | Corporate Officer, CMO Oncology and Head of Japan Development Division | |
| subsidiary | SymBio Pharma USA, Inc. Durham, North Carolina, USA |
|